Abiomed Inc (ABMD) Return on Equity ROE from the second quarter 2023 to second quarter 2022 and annually, average high and low, overall ranking from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Abiomed Inc   (NASDAQ: ABMD)

Abiomed Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Abiomed Inc in the second quarter 2023?
Abiomed Inc achieved a return on average equity (ROE) of 17.75 % in its second quarter 2023, which is below Abiomed Inc 's average return on equity, which stands at 18.63%.

ROE has advanced compared to 14.86% in the first quarter 2023, due to net income growth.

Within the Medical Equipment & Supplies industry 22 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 1000, from total ROE ranking in the first quarter 2023 at 1178.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter		 (Mar 31 2022)
IV. Quarter		 (Dec 31 2021)
III. Quarter		 (Sep 30 2021)
II. Quarter
Y / Y Equity Change 11.21 % 17.49 % 13.06 % 13.6 % -
Y / Y Net Income Change 86.35 % - 6.1 % -26.05 % -8.45 %
Net Income (TTM) in Millions 267 218 137 133 149
Return On Equity (TTM) 17.75 % 14.86 % 9.7 % 9.76 % 11.29 %
ABMD's Total Ranking # 1000 # 1178 # 1706 # 1853 # 1532
Equity (TTM) in Millions 1,540 1,536 1,503 1,433 1,385
Seq. Equity Change 0.23 % 2.19 % 4.91 % 3.49 % 5.89 %
Seq. Net Income Change 94.55 % -9.57 % 31.85 % -19.67 % -

Back to ABMD Management Effectiveness >> ABMD's 5 Years Annual ROE >> Compare ABMD ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 23
Sector # 98
Overall # 1000

Return On Equity Statistics
High Average Low
54.58 %
18.63 %
4.08 %
(Mar 31 2015)   (Sep 30 2013)





ABMD Annual Return On Equity (Mar 31 2022)
2022		 (Mar 31 2021)
2021		 (Mar 31 2020)
2020		 (Mar 31 2019)
2019		 (Mar 31 2018)
2018
Total Equity in Millions 1,503 1,330 1,065 937 690
Y / Y Equity Change 13.06 % 24.8 % 13.72 % 35.87 % 52.53 %
Net Income in Millions 137 226 203 259 112
Y / Y Net Income Change -39.47 % 11.09 % -21.62 % 130.91 % 115.23 %
Return On Equity 9.08 % 16.96 % 19.05 % 27.65 % 16.27 %

Back to ABMD Management Effectiveness >> ABMD's 5 Years Annual ROE >> Compare ABMD ROE to its Competitors




Annual Roe Comment
In 2022 ROE decreased compared to the previous year to 9.08 %, due to deterioration of net income.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ABMD's' Return on Equity at Yahoo Finance
ABMD's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ABMD's Competitors
Subscribers only: Roe for Abiomed Inc 's Suppliers
Subscribers only: Return On Equity for ABMD's Customers




Companies with similar Return On Equity at Sep 30 2022, within Healthcare Sector ROE
Prophase Labs Inc   48.24 %
Orgenesis Inc   46.95 %
Nrc Health  45.90 %
3m Company  45.36 %
Zoetis Inc   44.76 %
Iteos Therapeutics Inc   42.61 %
REST EZ Inc.  41.68 %
Medpace Holdings Inc   41.39 %
Chemed Corporation  38.89 %
Jrsis Health Care Corp  37.46 %
Merck and Co Inc   36.57 %
Pfizer Inc  35.00 %
Exelixis Inc   34.70 %
Carlisle Companies Incorporated  31.28 %
Shockwave Medical Inc   30.08 %
Ironwood Pharmaceuticals inc   29.82 %
Retractable Technologies Inc  29.12 %
Dariohealth Corp   28.80 %
Catalyst Pharmaceuticals Inc   28.53 %
Vertex Pharmaceuticals Inc  28.48 %
Humacyte Inc   28.21 %
Elite Pharmaceuticals Inc   27.77 %
Corcept Therapeutics Inc  27.49 %
Bruker Corporation  27.29 %
Hologic Inc  27.14 %
Precigen Inc   26.84 %
Regeneron Pharmaceuticals Inc   26.58 %
West Pharmaceutical Services Inc   26.39 %
Zynex inc   26.05 %
Johnson and Johnson  25.57 %

Date modified: 2026-08-29T17:31:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.